Cytokine, Anti-SARS-CoV-2 Antibody, and Neutralizing Antibody Levels in Conventional Blood Donors Who Have Recovered from COVID-19

The Relationship between Peripheral Immune Response and Disease Severity in SARS‐CoV‐2‐infected Subjects: A Cross‐sectional Study

(2022) Laura Otto Walter et al.   IMMUNOLOGY

ABO blood group does not influence the level of anti‐SARS‐CoV ‐2 antibodies in convalescent plasma donors

(2022) Klemen Žiberna et al.   TRANSFUSION

High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial

(2022) Andrea Alemany et al.   Lancet Respiratory Medicine

Early Outpatient Treatment for Covid-19 with Convalescent Plasma

(2022) David J. Sullivan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy of early transfusion of convalescent plasma with high‐titer SARS‐CoV ‐2 neutralizing antibodies in hospitalized patients with COVID ‐19

(2022) Cristina Sanz et al.   TRANSFUSION

Convalescent Plasma for Hospitalized COVID-19 Patients: A Single-Center Experience

(2022) Massimo Franchini et al.   Life-Basel

Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma

(2022) Lise J. Estcourt et al.   ANNALS OF INTERNAL MEDICINE

COVID-19 convalescent plasma composition and immunological effects in severe patients

(2021) Yeny Acosta-Ampudia et al.   JOURNAL OF AUTOIMMUNITY

Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection

(2021) Xiao-Lin Jiang et al.   Nature Communications

Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature

(2021) Ariel Munitz et al.   Scientific Reports

Potential use of convalescent plasma for SARS-CoV-2 prophylaxis and treatment in immunocompromised and vulnerable populations

(2021) Daniele Focosi et al.   Expert Review of Vaccines

Tocilizumab in COVID-19: a meta-analysis, trial sequential analysis, and meta-regression of randomized-controlled trials

(2021) Timothy Arthur Chandos Snow et al.   INTENSIVE CARE MEDICINE

Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

(2021) Cathrine Axfors et al.   BMC INFECTIOUS DISEASES

Immunological effects of convalescent plasma therapy for coronavirus: a scoping review

(2021) Behnaz Esmaeili et al.   BMC INFECTIOUS DISEASES

Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency

(2021) Julia Lang-Meli et al.   JOURNAL OF CLINICAL IMMUNOLOGY

IL-17A in COVID-19 Cases: a meta-analysis

(2021) Sukayna Fadlallah et al.   Journal of Infection in Developing Countries

Elevated cytokines and chemokines in peripheral blood of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma

(2021) Stacey L. Fanning et al.   PLoS Pathogens

Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19

(2021) Lowell Ling et al.   Frontiers in Immunology

Efficacy and safety of convalescent plasma therapy in patients with moderate-to-severe COVID-19: A non-randomized comparative study with historical control in a referral hospital in Indonesia

(2021) Johan Kurnianda et al.   Journal of Infection and Public Health

Early Transfusion of Convalescent Plasma Improves the Clinical Outcome in Severe SARS-CoV2 Infection

(2021) Eszter Fodor et al.   Infectious Diseases and Therapy

Treatment of COVID-19 Patients with Convalescent Plasma

(2020) Eric Salazar et al.   AMERICAN JOURNAL OF PATHOLOGY

Convalescent plasma in Covid-19: Possible mechanisms of action

(2020) Manuel Rojas et al.   AUTOIMMUNITY REVIEWS

The convalescent sera option for containing COVID-19

(2020) Arturo Casadevall et al.   JOURNAL OF CLINICAL INVESTIGATION

Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals

(2020) Yuan Liu et al.   NATURE

Use of convalescent plasma in hospitalized patients with COVID-19: case series

(2020) Livia Hegerova et al.   BLOOD

Longitudinal analyses reveal immunological misfiring in severe COVID-19

(2020) Carolina Lucas et al.   NATURE

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

(2020) Ventura A. Simonovich et al.   NEW ENGLAND JOURNAL OF MEDICINE

Manufacturing of convalescent plasma of COVID-19 patients: Aspects of quality

(2020) Viola Hähnel et al.   PLoS One

Cytokine and Chemokine Levels in COVID-19 Convalescent Plasma

(2020) Tania S Bonny et al.   Open Forum Infectious Diseases